Cargando…
Arsenic in leukemia: A RSKy business
It has been known for many years that arsenic trioxide (As(2)O(3); ATO) is an effective therapy for acute promyelocytic leukemia but has little activity against other forms of the disease. ATO has diverse modes of action, but is well known to generate high levels of reactive oxygen species in cells...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926878/ https://www.ncbi.nlm.nih.gov/pubmed/24025257 http://dx.doi.org/10.4161/cbt.26159 |